133 related articles for article (PubMed ID: 38341171)
1. Risk characterization of N-nitrosodimethylamine in pharmaceuticals.
Paustenbach DJ; Brown SE; Heywood JJ; Donnell MT; Eaton DL
Food Chem Toxicol; 2024 Apr; 186():114498. PubMed ID: 38341171
[TBL] [Abstract][Full Text] [Related]
2. Permitted daily exposure limits for noteworthy N-nitrosamines.
Johnson GE; Dobo K; Gollapudi B; Harvey J; Kenny J; Kenyon M; Lynch A; Minocherhomji S; Nicolette J; Thybaud V; Wheeldon R; Zeller A
Environ Mol Mutagen; 2021 Jun; 62(5):293-305. PubMed ID: 34089278
[TBL] [Abstract][Full Text] [Related]
3. Use of the benchmark-dose (BMD) approach to derive occupational exposure limits (OELs) for genotoxic carcinogens: N-nitrosamines.
Blum K; FitzGerald R; Wilks MF; Barle EL; Hopf NB
J Appl Toxicol; 2023 Aug; 43(8):1183-1200. PubMed ID: 36840679
[TBL] [Abstract][Full Text] [Related]
4. DNA single-strand breaks and toxicity induced by 4-(methyl-nitrosamino)-1-(3- pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver.
Jorquera R; Castonguay A; Schuller HM
Carcinogenesis; 1994 Feb; 15(2):389-94. PubMed ID: 8313533
[TBL] [Abstract][Full Text] [Related]
5. Toxic and carcinogenic effects of nitrosodimethylamine in mink.
Koppang N; Rimeslåtten H
IARC Sci Publ (1971); 1976; (14):443-52. PubMed ID: 1002208
[TBL] [Abstract][Full Text] [Related]
6. Development of a tolerable daily intake for N-nitrosodimethylamine using a modified benchmark dose methodology.
Fitzgerald DJ; Robinson NI
J Toxicol Environ Health A; 2007 Oct; 70(19):1670-8. PubMed ID: 17763085
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry of O6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA). Implications for the mechanism of NDMA hepatocarcinogenesis.
Souliotis VL; Chhabra S; Anderson LM; Kyrtopoulos SA
Carcinogenesis; 1995 Oct; 16(10):2381-7. PubMed ID: 7586139
[TBL] [Abstract][Full Text] [Related]
8. Effects of cytosol on mutagenesis induced by N-nitrosodimethylamine, N-nitrosomethylurea and alpha-acetoxy-N-nitrosodimethylamine in different strains of Salmonella: evidence for different ultimate mutagens from N-nitrosodimethylamine.
Guttenplan JB
Carcinogenesis; 1993 May; 14(5):1013-9. PubMed ID: 8504462
[TBL] [Abstract][Full Text] [Related]
9. Comparison of transplacental and neonatal initiation of mouse lung and liver tumors by N-nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and promotability by a polychlorinated biphenyls mixture (Aroclor 1254).
Beebe LE; Kim YE; Amin S; Riggs CW; Kovatch RM; Anderson LM
Carcinogenesis; 1993 Aug; 14(8):1545-8. PubMed ID: 8353839
[TBL] [Abstract][Full Text] [Related]
10. Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite.
Schlingemann J; Boucley C; Hickert S; Bourasseau L; Walker M; Celdran C; Chemarin T; Pegues C; Fritzsche M; Keitel J; Goettsche A; Seegel M; Leicht S; Guessregen B; Reifenberg P; Wetzel S; Müller T; Schooren F; Schuster T; Liebhold M; Kirsch A; Krueger P; Saal C; Mouton B; Masanes S
Int J Pharm; 2022 May; 620():121740. PubMed ID: 35421534
[TBL] [Abstract][Full Text] [Related]
11. Physiologically-based pharmacokinetic model for evaluating gender-specific exposures of N-nitrosodimethylamine (NDMA).
Kang DW; Kim JH; Choi GW; Cho SJ; Cho HY
Arch Toxicol; 2024 Mar; 98(3):821-835. PubMed ID: 38127128
[TBL] [Abstract][Full Text] [Related]
12. N-Nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulations.
Lynch AM; Howe J; Hildebrand D; Harvey JS; Burman M; Harte DSG; Chen L; Kmett C; Shi W; McHugh CF; Patel KK; Junnotula V; Kenny J; Haworth R; Wills JW
Mutagenesis; 2024 Mar; 39(2):96-118. PubMed ID: 38183622
[TBL] [Abstract][Full Text] [Related]
13. Intake of tobacco nitrosamines of smokers in various provinces of China and their cancer risk: A meta-analysis.
Li X; Ye Z; Wang J; Lin P; Zhang X; Xie S; Chen C
J Environ Sci (China); 2024 Jul; 141():249-260. PubMed ID: 38408825
[TBL] [Abstract][Full Text] [Related]
14. Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine.
Zeng T; Mitch WA
Carcinogenesis; 2016 Jun; 37(6):625-634. PubMed ID: 26992900
[TBL] [Abstract][Full Text] [Related]
15. A Bioanalytical Method for Quantification of N-nitrosodimethylamine (NDMA) in Human Plasma and Urine with Different Meals and following Administration of Ranitidine.
De Palma R; Patel V; Florian J; Keire D; Selaya D; Strauss DG; Rouse R; Matta MK
J Pharm Sci; 2023 May; 112(5):1315-1323. PubMed ID: 36736776
[TBL] [Abstract][Full Text] [Related]
16. Effect of ascorbic acid and green tea on endogenous formation of N-nitrosodimethylamine and N-nitrosopiperidine in humans.
Vermeer IT; Moonen EJ; Dallinga JW; Kleinjans JC; van Maanen JM
Mutat Res; 1999 Jul; 428(1-2):353-61. PubMed ID: 10518007
[TBL] [Abstract][Full Text] [Related]
17. Drinking water as a proportion of total human exposure to volatile N-nitrosamines.
Hrudey SE; Bull RJ; Cotruvo JA; Paoli G; Wilson M
Risk Anal; 2013 Dec; 33(12):2179-208. PubMed ID: 23786353
[TBL] [Abstract][Full Text] [Related]
18. Patient In-Use Stability Testing of FDA-Approved Metformin Combination Products for N-Nitrosamine Impurity.
Dharani S; Mohamed EM; Rahman Z; Khan MA
AAPS PharmSciTech; 2024 Jan; 25(1):19. PubMed ID: 38267707
[TBL] [Abstract][Full Text] [Related]
19. NITROSOGENESIS, ANTIDEPRESSANTS AND THE SERTRALIN INDUCED NEVUS ASSOCIATED CUTANEOUS MELANOMA: THE NDMA/ NNK (NDSRIS) CONTAMINATION AS MOST POTENT MELANOMA INDUCTORS: ALEA IACTA EST.
Tchernev G
Georgian Med News; 2023 Sep; (342):47-53. PubMed ID: 37991956
[TBL] [Abstract][Full Text] [Related]
20. Substrate concentration dependency of N-nitrosodimethylamine and N-nitrosomethylbenzylamine metabolism in rat liver.
Kawanishi T; Ohno Y; Takahashi A; Takanaka A; Kasuya Y; Omori Y
Carcinogenesis; 1985 Jun; 6(6):823-7. PubMed ID: 4006068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
